Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic Leukemia

Condition:   Relapsed/Refractory Large Granular T Lymphocytic Leukemia Intervention:   Drug: Linperlisib Sponsors:   Institute of Hematology & Blood Diseases Hospital;   YL-Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials